Funding
Indiana_CTSI_Header

Research Funding

  • NIH R01CA203737: Targeting human cancers with hemizygous deletion of TP53
  • NIH R01CA206366: Nanotechnology enabled targeting of p53 deficiency in human cancer
  • NIH R21CA213535: Engineering antibody drug conjugates to target p53-defective triple negative breast cancer
  • NIH R21CA185742: Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
  • IU School of Medicine Strategic Research Initiative fund
  • Vera Bradley Foundation fund
  • Walter A. and Laura W. Deutsch Scholarship